TEL:18017582758 Sales1@nextech-x.com

       Hangzhou Qiantang Longyue Biotechnology Co., Ltd. was established in February 2021. With GMP-compliant Class 10,000 (Grade C) cleanrooms and well-equipped physical, chemical, and microbiological laboratories, we have established a quality management system that meets global regulatory requirements for R&D, production, and testing, and have obtained ISO 13485 certification.

       Adhering to the business philosophy of "enhancing medical quality through innovative medical technology," we are dedicated to the customized research, development, and production of new drug transfer and delivery systems, high-end pharmaceutical packaging materials, and new drug-device combination products. We aim to become a leading enterprise in the research, development, and production of new drug delivery devices and high-end pharmaceutical packaging materials in China, as well as a solid and reliable partner for biopharmaceutical, vaccine, and drug research and manufacturing enterprises in China, contributing to the development of China's pharmaceutical industry.

       With rich experience and professional expertise in polymer drug infusion devices and active precision medical devices, we have established four core technology platforms. Leveraging these platforms, we have developed a diverse product pipeline covering areas such as drug preparation/transfer, new ophthalmic drug delivery, new vaccine delivery, aesthetic injection delivery, and drug-device combination products for biologic drugs.

       Our management, research and development, and operation teams have extensive work experience in medical device research and development, strategic planning, regulatory affairs, production management, and market operations, and we have established an efficient industrialization system for the research and development, regulatory compliance, manufacturing, and quality management of medical devices and drug-device combination products.

We have established a comprehensive quality system, organizational structure, and QC laboratory, and has obtained ISO 13485 certification.Gross floor area: 2,914 m2, including:

① Production workshop: 1,000 m2, including a Grade C cleanroom of 720 m2;

② Physical, chemical, and microbiological laboratories totaling 213 m2 (including three Class 10,000 microbiological laboratories)

Mission values

Develop new drug delivery systems and high-end drug packaging materials, establish a core technology platform, solve the pain points of drug manufacturing and clinical use, and help improve China's medical quality.

Development course
Feb 2021
The company was established in Hangzhou City, Zhejiang Province;
Apr 2022
Obtained ISO13485 system certification;
Jun 2022
Obtain the first medical device registration certificate;
ALL TIME, ANY TIME, ANYWHERE ON TIME.

Copyright: Hangzhou Qiantang Longyue Biotechnology Co., Ltd. 

Technical support: Seven Star Network